Clinical Trials Directory

Trials / Completed

CompletedNCT03361293

Cognitive Training and tDCS for Children With FASD

Neuromodulation Augmented Cognitive Remediation to Improve Executive Dysfunction in Fetal Alcohol Spectrum Disorder (FASD)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
44 (actual)
Sponsor
University of Minnesota · Academic / Other
Sex
All
Age
10 Years – 16 Years
Healthy volunteers
Not accepted

Summary

This is a randomized placebo-controlled trial of cognitive training with transcranial direct current stimulation (tDCS) for children and adolescents (ages 10 - 16 years) with prenatal alcohol exposure (PAE).

Detailed description

Prenatal alcohol exposure (PAE) has profound detrimental effects on brain development and, as a result, has permanent consequences for cognition, learning, and behavior. Individuals with Fetal Alcohol Spectrum Disorders (FASD) commonly have a range of neurocognitive impairments that directly lead to practical problems with learning, attention, working memory, task planning/execution, and decision making, among other areas of functioning. Despite the profound public health burden posed by FASD, there have been very few treatment studies in this population. This study will examine the effects of a cognitive remediation training augmented with tDCS in children and adolescents with PAE. Functional magnetic resonance imaging will be collected to provide preliminary data of brain circuitry changes created by this intervention. The study involves a baseline visit with cognitive testing, MRI, 5 sessions of tDCS (including the baseline visit), and a 6th visit for cognitive testing and MRI. All sessions will be completed within a 28 to 56 day time window.

Conditions

Interventions

TypeNameDescription
DEVICEActive tDCSActive Transcranial Direct Current Stimulation (tDCS) administered with a Neuroelectrics StarStim Enobio cap system (active mode)
BEHAVIORALCognitive trainingBrainHQ Computerized cognitive training
DEVICESham tDCSSham Transcranial Direct Current Stimulation (tDCS) administered with a Neuroelectrics StarStim Enobio cap system (sham mode)

Timeline

Start date
2017-11-20
Primary completion
2020-01-30
Completion
2020-01-30
First posted
2017-12-04
Last updated
2021-03-17
Results posted
2021-02-16

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03361293. Inclusion in this directory is not an endorsement.